The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ozempic

1.34 milligram(s)/millilitre Solution for infusion in pre-filled syringe

Novo Nordisk A/SEU/1/17/1251/002-006

Main Information

Trade NameOzempic
Active Substancessemaglutide
Strength1.34 milligram(s)/millilitre
Dosage FormSolution for infusion in pre-filled syringe
Licence HolderNovo Nordisk A/S
Licence NumberEU/1/17/1251/002-006

Group Information

ATC CodeA10BJ06 semaglutide

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back